Richard Spector
Corporate Officer/Principal bei FEMASYS INC.
Vermögen: - $ am 31.05.2024
Aktive Positionen von Richard Spector
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
FEMASYS INC. | Corporate Officer/Principal | 01.02.2024 | - |
Karriereverlauf von Richard Spector
Ehemalige bekannte Positionen von Richard Spector
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
INSULET CORPORATION | Corporate Officer/Principal | - | - |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Vertrieb & Marketing | - | - |
QLibrium, Inc.
QLibrium, Inc. Medical DistributorsDistribution Services QLibrium, Inc. distributes on-body drug delivery systems. The private company is located in the US. | Corporate Officer/Principal | - | - |
Ausbildung von Richard Spector
The California State University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Sales & Marketing | 1 |
Sektoral
Health Technology | 3 |
Electronic Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
FEMASYS INC. | Electronic Technology |
INSULET CORPORATION | Health Technology |
Private Unternehmen | 2 |
---|---|
QLibrium, Inc.
QLibrium, Inc. Medical DistributorsDistribution Services QLibrium, Inc. distributes on-body drug delivery systems. The private company is located in the US. | Distribution Services |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Richard Spector
- Erfahrung